Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Watchlist Manager
Sun Pharmaceutical Industries Ltd Logo
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Watchlist
Price: 1 747.85 INR -0.78% Market Closed
Market Cap: 4.2T INR
Have any thoughts about
Sun Pharmaceutical Industries Ltd?
Write Note

Sun Pharmaceutical Industries Ltd
Goodwill

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sun Pharmaceutical Industries Ltd
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Goodwill
â‚ą87.7B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
14%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Goodwill
â‚ą5.5B
CAGR 3-Years
-1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Goodwill
â‚ą32.5B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
3%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Goodwill
â‚ą52.7B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Goodwill
â‚ą3.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
36%
M
Mankind Pharma Ltd
NSE:MANKIND
Goodwill
â‚ą200.2m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sun Pharmaceutical Industries Ltd
Glance View

Market Cap
4.2T INR
Industry
Pharmaceuticals
Economic Moat
Narrow

Sun Pharmaceutical Industries Ltd. is a leading global pharmaceutical company based in India, renowned for its commitment to producing high-quality generic and specialty medicines. Founded in 1983, Sun Pharma has evolved into one of the largest pharmaceutical companies in India and the fifth largest globally in the generic market. With a robust portfolio that encompasses various therapeutic areas, including cardiology, psychiatry, neurology, and oncology, the company has built a solid reputation for innovation and reliability. A strong emphasis on research and development drives Sun Pharma’s growth, helping it to continuously expand its product offerings and tap into new markets, as evidenced by its strategic acquisitions and partnerships over the years. For investors, Sun Pharmaceutical presents a compelling opportunity, underpinned by its solid financial performance and a forward-looking strategic vision. The company's extensive presence in over 150 countries combined with a diverse portfolio fuels its competitive edge in the global pharmaceutical landscape. With a solid track record of profitability and a commitment to enhancing shareholder value, Sun Pharma is well-positioned to capture growth in emerging markets and capitalize on advancements in biologics and complex generics. Moreover, the company’s focus on sustainability and ethical practices resonates in an increasingly socially conscious investment environment, making it an appealing prospect for investors looking to diversify their portfolios while supporting a responsible industry leader.

SUNPHARMA Intrinsic Value
1 047.73 INR
Overvaluation 40%
Intrinsic Value
Price

See Also

What is Sun Pharmaceutical Industries Ltd's Goodwill?
Goodwill
87.7B INR

Based on the financial report for Sep 30, 2024, Sun Pharmaceutical Industries Ltd's Goodwill amounts to 87.7B INR.

What is Sun Pharmaceutical Industries Ltd's Goodwill growth rate?
Goodwill CAGR 10Y
14%

Over the last year, the Goodwill growth was -2%. The average annual Goodwill growth rates for Sun Pharmaceutical Industries Ltd have been 11% over the past three years , 8% over the past five years , and 14% over the past ten years .

Back to Top